BMRN

#861
BioMarin Pharmaceuticals Inc
55.47 USD
+1.08%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
55.47
55.47
1年のレンジ
50.76
66.28
1日の変化
+1.08%
月次変化
-2.12%
6か月変化
+5.98%
1年の変化
-6.96%
以前の終値
54.88
始値
55.47
Bid
Ask
安値
55.47
High
55.47
ボリューム
144
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 10.67 B
  • Employee 3 221
  • Founded N/A
  • CEO Alexander Hardy
  • Website www.biomarin.com
  • Headquarter Delaware, United States
  • FIGI BBG000CZWZ05
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
33.02
売上高対価格比率
3.64

BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.

ニュース